This study aims to evaluate a new medication being developed for erectile dysfunction (ED).
Erectile dysfunction (ED) is a common condition where a man cannot get or keep an erection firm enough for sexual activity. It can affect confidence, relationships, and overall quality of life, and may be caused by physical, hormonal, or psychological factors. While medications are approved for use which improve blood flow and are widely used, they do not work for everyone.
The study drug combines sildenafil (commonly known as Viagra®) with cabergoline, which acts on brain and hormone pathways. It aims to improve effectiveness especially for those who do not respond well to current treatments while potentially reducing side effects.
Requirements
- Male
- Healthy
- 18 - 65 years old
- BMI 18 - 32 kg/m2
- Not taking any medications
- Non-smoker or Occasional smoker
Study visits
5 nights, 1 clinic visit